Search research articles
Contact Us
Filters
Showing results (321-330 of 326) with videos related to
Page
of 33
Sort By:
You have reached the last page of results.
This site can display upto 326 results.
Journal of Neuroimmunology
|
June 1, 1997
Results of a phase I clinical trial of a T-cell receptor peptide vaccine in patients with multiple sclerosis. I. Analysis of T-cell receptor utilization in CSF cell populations
D B Wilson, A B Golding, R A Smith, et al.
The Journal of Biological Chemistry
|
November 5, 1985
Isolation and characterization of the inositol cyclic phosphate products of polyphosphoinositide cleavage by phospholipase C. Physiological effects in permeabilized platelets and Limulus photoreceptor cells
D B Wilson, T M Connolly, T E Bross, et al.
The Journal of Biological Chemistry
|
July 5, 1992
Stereoselective hydrolysis catalyzed by related beta-1,4-glucanases and beta-1,4-xylanases
J Gebler, N R Gilkes, M Claeyssens, et al.
Journal of the American College of Cardiology
|
July 1, 1992
Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial
S Z Goldhaber, C M Kessler, J A Heit, et al.
The Annals of Pharmacotherapy
|
September 12, 2000
A randomized, crossover comparison of warfarin products in the treatment of chronic atrial fibrillation
R T Weibert, B F Yeager, A K Wittkowsky, et al.
Journal of Neuroimmunology
|
June 1, 1997
Results of a phase I clinical trial of a T-cell receptor vaccine in patients with multiple sclerosis. II. Comparative analysis of TCR utilization in CSF T-cell populations before and after vaccination with a TCRV beta 6 CDR2 peptide
D P Gold, R A Smith, A B Golding, et al.
Page
of 33
Search research articles
Search
Showing results (321-330 of 326) with videos related to
Sort By:
Page
of 33
You have reached the last page of results.
This site can display upto 326 results.
Journal of Neuroimmunology
|
June 1, 1997
Results of a phase I clinical trial of a T-cell receptor peptide vaccine in patients with multiple sclerosis. I. Analysis of T-cell receptor utilization in CSF cell populations
D B Wilson, A B Golding, R A Smith, et al.
The Journal of Biological Chemistry
|
November 5, 1985
Isolation and characterization of the inositol cyclic phosphate products of polyphosphoinositide cleavage by phospholipase C. Physiological effects in permeabilized platelets and Limulus photoreceptor cells
D B Wilson, T M Connolly, T E Bross, et al.
The Journal of Biological Chemistry
|
July 5, 1992
Stereoselective hydrolysis catalyzed by related beta-1,4-glucanases and beta-1,4-xylanases
J Gebler, N R Gilkes, M Claeyssens, et al.
Journal of the American College of Cardiology
|
July 1, 1992
Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial
S Z Goldhaber, C M Kessler, J A Heit, et al.
The Annals of Pharmacotherapy
|
September 12, 2000
A randomized, crossover comparison of warfarin products in the treatment of chronic atrial fibrillation
R T Weibert, B F Yeager, A K Wittkowsky, et al.
Journal of Neuroimmunology
|
June 1, 1997
Results of a phase I clinical trial of a T-cell receptor vaccine in patients with multiple sclerosis. II. Comparative analysis of TCR utilization in CSF T-cell populations before and after vaccination with a TCRV beta 6 CDR2 peptide
D P Gold, R A Smith, A B Golding, et al.
Page
of 33